investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of TGF-beta antagonists for cancer therapy

Lalage Wakefield

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Peter Watson

BC Cancer Agency

Vancouver, Canada

Related projects

Thomas Sayers

Promoting Tumor Cell Apoptosis by Death Ligands

Breast

Susan L Teitelbaum

Breast Cancer Genomics in Windows of Susceptibility to Endocrine Disruptors

Breast

Colleen Ann Sweeney

LRIG Proteins in Mammary gland Development and Carcinogenesis

Breast

Joe W Gray

Model-based Predictions of Responses RTK Pathway Therapies

Breast

Roger W Howell

Radiation induced bystander effects in radium-223 therapy

Breast

Radiation Oncology

Pier Paolo Pandolfi

PTEN in ontogenesis and tumor suppression

Breast

Michael J Holliday

Mapping and Controlling the Segmental Dynamic Networks of Cyclophilin A as they Relate to Enzymatic Function

Breast

Joseph Barchi

Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines

Breast

Che-Wei Chang

Systematic identification of resistance mechanisms to HER2-targeted therapies in breast cancer.

Breast